ETFs Are Net Sellers of Clorox (CLX) on Nov. 2
ETFs were net sellers of Clorox (CLX) on Nov. 2, with RDIV reducing its stake by 99.92% and selling $21.1 million worth of shares. Total net ETF selling amounted to $14.0 million, ending a four-day buying streak. Clorox has a market cap of $11.3 billion, a P/E of 16.89, and a dividend yield of 5.23%.
How this was made

The 30-second read
Why it matters
ETF net selling may create short‑term downside risk, but fundamentals remain stable.
Market read
ETF flow data provides a modest, short‑term signal for CLX traders.
What to watch
Potential hidden buying from other funds not captured in the snapshot.
Background
Clorox (CLX) is a $11.3 B market‑cap consumer‑defensive stock with a 5.23% dividend yield.
Ticker impact
ETFs sold a net $14.0 million of Clorox shares on Monday, with RDIV alone shedding $21.1 million.
downward pressure as the market prices in the net selling
ETF outflows of $14 M represent a notable short‑term supply increase; no offsetting buying pressure was reported.
Market effects
Limited; reflects a brief shift in consumer‑defensive ETF positioning.
US equity market only.
Low.
Counterpoint
If the sell‑off is temporary, CLX could rebound on its solid dividend yield.
Key entities
- ETFRDIV
Largest seller, offloaded $21.1 M of CLX.
- ETFXLP
Sold $0.9 M of CLX.
- ETFSPHD
Sold $0.3 M of CLX.



